SBIR/STTR Research Award

New Techniques for Microarray Fabrication and Analysis

Award identifier c4973a7cee2f8f9f21af554d498da5e543a3e2f09fd052917798c7de1a02540eAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
BIOMACHINES, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Current microarray techniques are subject to inherent variability directly related to the inability of array deposition systems to accurately identify and record the location of arrayed materials and to communicate this information to follow-on systems for use in post-deposition array processing, readout and analysis. The inability to easily identify, record and communicate the accurate location of arrayed materials and any spatial distortions introduced in arrayed materials during post-deposition processing are barriers to automation and integration of array production, processing and analysis. In this SBIR Phase I proposal, Biomachines proposes innovative techniques to incorporate geometric features as "fiducial marks" on microarray and biochip substrates to provide common measurable points for all steps in fabrication, processing and analysis. The use of fiducial marks as fixed reference points will enable a device (e.g., arrayer, imager) to automatically, accurately and repeatedly: align and orient substrates, deposit materials on substrates at pre-determined locations (i.e., "targeting") and identify the location and orientation of materials previously deposited on substrates. BioMachines goal is to automate the entire microarray data extraction process, simplifying analysis software, speeding data production and significantly reducing the variability encountered microarray studies. Under Phase I funding, BioMachines will modify our existing vision guided precision placement platform, including software, to use our proposed fiducial mark technology and will demonstrate the capabilities. BioMachines fiducial mark technology will have broad applications in genomics, proteomics, bioinformatics, biochips, biosensors, cytology and other applications where there is a requirement for repeatedly locating or performing actions on features sized below a few hundred microns.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.